Peng Lu
Chief Tech/Sci/R&D Officer bij PHARVARIS N.V.
Vermogen: 785 740 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Peng Lu
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 20 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Peng Lu via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
NESTLÉ S.A. | Food: Major Diversified | Corporate Officer/Principal | |
PORTAGE BIOTECH INC. | Biotechnology | Director/Board Member | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Top Institute Pharma
Top Institute Pharma BiotechnologyHealth Technology Part of Center for Translational Molecular Medicine, Top Institute Pharma provides pharmaceutical research services. The private company is based in Leiden, Netherlands. Top Institute Pharma was acquired by Center for Translational Molecular Medicine on June 09, 2015. | Biotechnology | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Director of Finance/CFO | |
UCB | Pharmaceuticals: Major | Director/Board Member | |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Founder | |
Karolinska Institutet | College/University | Doctorate Degree | |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Chalmers University of Technology | College/University | Director/Board Member | |
University of Uppsala | College/University | Corporate Officer/Principal | |
CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Galderma International SAS
Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director of Finance/CFO | |
University of Utrecht | College/University | Doctorate Degree | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
ESCP Europe Campus Paris | College/University | Masters Business Admin | |
Nestlé Belgilux SA
Nestlé Belgilux SA Food: Meat/Fish/DairyConsumer Non-Durables Part of Nestlé SA, Nestlé Belgilux SA is a private company based in Brussels, Belgium. The Belgian company is a global leader in nutrition, health, and wellness, with offices, factories, and research and development centers worldwide. The company offers various job opportunities in technical production services, research and development, and other areas. Additionally, the company provides advice from dieticians on how to prepare delicious meals that cater to all guests. The company's website also features information on nutrition, health, and wellness, as well as promotions and product information. | Food: Meat/Fish/Dairy | Corporate Officer/Principal | |
Novartis Pharma NV
Novartis Pharma NV Pharmaceuticals: MajorHealth Technology Founded in 1996, Novartis Pharma NV is a Belgian pharmaceutical company that develops medicines. The private company is based in Brussels, Belgium and is a subsidiary of Novartis AG. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Europe BV
Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Organon International BV | President | ||
HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
VOLUNTIS S.A. | Packaged Software | Director/Board Member | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Complix NV
Complix NV Pharmaceuticals: MajorHealth Technology Complix NVengages in the development of biopharmaceutical company developing Alphabodies, a pipeline of transformative protein therapeutics. The Company is currently focusing its internal research and development activities on oncology and autoimmune diseases. Its therapeutic Alphabodies focuses on the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis and multiple sclerosis, and infectious diseases, and viral diseases such as influenza, HIV, and RSV. The company was founded by Mark Vaeck and Ignace Lasters in 2008 and is headquartered in Diepenbeek, Belgium. | Pharmaceuticals: Major | Chairman | |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Chairman | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Wyeth Pharmaceuticals (Belgium) | Corporate Officer/Principal | ||
VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Uppsala University Hospital operates a hospital. | Hospital/Nursing Management | Corporate Officer/Principal | |
Top Sector Life Sciences & Health | Director/Board Member | ||
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman | |
WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Pharmaceuticals: Major | Director of Finance/CFO | |
Renault Asia Pacific Ltd. | Director of Finance/CFO | ||
Nefarma | Director/Board Member | ||
IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member | |
ROCKET PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Therachon Holding GmbH
Therachon Holding GmbH BiotechnologyHealth Technology Therachon Holding GmbH engages in the acquisition, management, financing, and disposal of participating interests in firms. It also acquires, holds, and disposes intellectual property rights. The company was founded on December 22, 2015 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Björks Matematik o Mera AB | Director/Board Member | ||
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Founder Founder Director/Board Member Chairman Director/Board Member Founder Director/Board Member Founder | |
Kosa Pharma GmbH | Founder Founder | ||
Rfidcompare Europe AB | Director/Board Member | ||
Enavate Sciences
Enavate Sciences Financial ConglomeratesFinance Enavate Sciences is a platform created by Patient Square Capital to support therapeutic companies in advancing medicines and enabling technologies to address patient needs. The company is based in Delaware. Enavate strives to empower a diverse portfolio of therapeutic companies to accelerate innovation through capital support and operational experience. James P. Boylan has been the CEO of the American company since 2022. | Financial Conglomerates | Private Equity Investor | |
NeoMedLight SAS
NeoMedLight SAS Medical SpecialtiesHealth Technology NeoMedLight SAS develops medical devices of phototherapy. It offers weaving, electronics, light and healthcare technologies. The company was founded by Pierre Saint-Girons and Brochier Cédric and is headquartered in Villeurbanne, France. | Medical Specialties | Corporate Officer/Principal |
Statistieken
Internationaal
Nederland | 13 |
Zweden | 13 |
Zwitserland | 8 |
België | 6 |
Frankrijk | 6 |
Sectoraal
Health Technology | 30 |
Consumer Services | 7 |
Consumer Non-Durables | 3 |
Finance | 3 |
Commercial Services | 2 |
Operationeel
Director/Board Member | 132 |
Corporate Officer/Principal | 41 |
Independent Dir/Board Member | 35 |
Founder | 16 |
Chairman | 12 |
Sterkste connecties
Insiders | |
---|---|
Martijn Kleijwegt | 33 |
Rémi Droller | 29 |
Berndt A. E. Modig | 23 |
Johannes G. C. P. Schikan | 22 |
Viviane Monges | 21 |
David Meeker | 19 |
Richard Gaster | 17 |
Robert Glassman | 16 |
Margareta Elisabeth Björk | 12 |
Jochen Knolle | 11 |
Michael Rome | 9 |
Joan Schmidt | 7 |
Anne Marie de Jonge Schuermans | 6 |
Anne Lesage | 5 |
Morgan Conn | 5 |